Editors' Note: Benefits and Risks of Epilepsy Surgery in Patients With Focal Cortical Dysplasia Type 2 in the Central Region
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In the research article entitled “Benefits and Risks of Epilepsy Surgery in Patients With Focal Cortical Dysplasia Type 2 in the Central Region,” Chassoux et al. described their findings from a retrospective review of preoperative and postoperative data for 60 patients with focal cortical dysplasia type 2 (FCD2) in the central region who underwent surgical resection. They reported that surgical resection led to seizure freedom in 88% of patients, and although 87% had early transitory postoperative deficits, 40% of these patients had total recovery. Abe noted that patients with FCD2 can experience neurologic deficits due to the location of the dysplasia and asked the authors to describe preoperative neurologic deficits for patients included in this study. Chassoux reported that 18% of patients experienced a preoperative deficit that was either permanent or fluctuating and they all experienced transitory worsening of this deficit postoperatively, but 36% subsequently had functional improvement. Chassoux also noted that 84% of patients with a normal neurologic examination preoperatively experienced a postoperative deficit.
In the research article entitled “Benefits and Risks of Epilepsy Surgery in Patients With Focal Cortical Dysplasia Type 2 in the Central Region,” Chassoux et al. described their findings from a retrospective review of preoperative and postoperative data for 60 patients with focal cortical dysplasia type 2 (FCD2) in the central region who underwent surgical resection. They reported that surgical resection led to seizure freedom in 88% of patients, and although 87% had early transitory postoperative deficits, 40% of these patients had total recovery. Abe noted that patients with FCD2 can experience neurologic deficits due to the location of the dysplasia and asked the authors to describe preoperative neurologic deficits for patients included in this study. Chassoux reported that 18% of patients experienced a preoperative deficit that was either permanent or fluctuating and they all experienced transitory worsening of this deficit postoperatively, but 36% subsequently had functional improvement. Chassoux also noted that 84% of patients with a normal neurologic examination preoperatively experienced a postoperative deficit.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- Received November 14, 2022.
- Accepted in final form November 14, 2022.
- © 2023 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan